We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$503M
AUM Growth
-$85.2M
Cap. Flow
-$69.1M
Cap. Flow %
-13.73%
Top 10 Hldgs %
34.85%
Holding
49
New
4
Increased
2
Reduced
37
Closed
3

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$18.1M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$14M
3
KMI icon
Kinder Morgan
KMI
+$10.3M
4
BNY
Bank of New York Mellon
BNY
+$740K
5
BMY icon
Bristol-Myers Squibb
BMY
+$51.5K

Top Sells

Rank Stock Value
1
KHC icon
Kraft Heinz
KHC
+$17.5M
2
AMGN icon
Amgen
AMGN
+$12.2M
3
XOM icon
ExxonMobil
XOM
+$12.1M
4
LOW icon
Lowe's Companies
LOW
+$4.26M
5
APTV icon
Aptiv
APTV
+$3.78M

Sector Composition

Rank Sector Weight
1 Healthcare 30.01%
2 Technology 13.31%
3 Consumer Discretionary 10.44%
4 Communication Services 9.33%
5 Financials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXN
26
DELISTED
Alexion Pharmaceuticals
ALXN
$13.1M 2.59%
+117,085
New +$14M
PM icon
27
Philip Morris
PM
$290B
$13M 2.59%
131,170
-20,190
-13% -$2.1M
JNJ icon
28
Johnson & Johnson
JNJ
$629B
$12.1M 2.4%
94,325
-9,695
-9% -$1.31M
CELG
29
DELISTED
Celgene Corp
CELG
$11.3M 2.24%
126,383
-8,860
-7% -$851K
EOG icon
30
EOG Resources
EOG
$75.1B
$11.3M 2.24%
106,980
-21,750
-17% -$2.35M
CB icon
31
Chubb
CB
$132B
$10.4M 2.07%
76,195
-9,800
-11% -$1.42M
CVX icon
32
Chevron
CVX
$386B
$10.1M 2%
88,385
-8,810
-9% -$1.05M
KMI icon
33
Kinder Morgan
KMI
$70.7B
$8.96M 1.78%
+594,965
New +$10.3M
BMY icon
34
Bristol-Myers Squibb
BMY
$130B
$2.64M 0.52%
41,700
+800
+2% +$51.5K
FE icon
35
FirstEnergy
FE
$27.2B
$983K 0.2%
28,900
– –
COST icon
36
Costco
COST
$421B
$886K 0.18%
4,700
-300
-6% -$56.6K
KO icon
37
Coca-Cola
KO
$373B
$877K 0.17%
20,200
-8,000
-28% -$359K
LLY icon
38
Eli Lilly
LLY
$1.09T
$867K 0.17%
11,200
+600
+6% +$48.3K
ADP icon
39
Automatic Data Processing
ADP
$107B
$851K 0.17%
7,500
-400
-5% -$46.6K
NVDA icon
40
NVIDIA
NVDA
$5.43T
$834K 0.17%
144,000
-24,000
-14% -$141K
IFF icon
41
International Flavors & Fragrances
IFF
$21.4B
$821K 0.16%
6,000
– –
AAPL icon
42
Apple
AAPL
$4.41T
$772K 0.15%
18,400
– –
BNY
43
Bank of New York Mellon
BNY
$111B
$685K 0.14%
+13,300
New +$740K
A icon
44
Agilent Technologies
A
$41.9B
$662K 0.13%
9,900
-4,500
-31% -$315K
GILD icon
45
Gilead Sciences
GILD
$168B
$656K 0.13%
8,700
-4,000
-31% -$318K
ZBH icon
46
Zimmer Biomet
ZBH
$18.7B
$622K 0.12%
5,871
-2,678
-31% -$311K
AMGN icon
47
Amgen
AMGN
$225B
– –
-70,135
Closed -$12.2M
KHC icon
48
Kraft Heinz
KHC
$29.1B
– –
-224,415
Closed -$17.5M
XOM icon
49
ExxonMobil
XOM
$657B
– –
-144,353
Closed -$12.1M
1
2

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q1 2018 Portfolio in Review

As of Q1 2018, Stralem & Co held 49 positions worth $503M, down 14% from $589M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Stralem & Co withdrew a net $69.1M in Q1 2018, closing 3 positions and reducing 37 holdings. Its most notable exit was Kraft Heinz, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Stralem & Co opened a new position in AbbVie worth $15.6M.

  • Stralem & Co's largest Q1 2018 buy was AbbVie: 164,415 shares worth $15.6M.
  • Stralem & Co added most to Bristol-Myers Squibb in Q1 2018, an estimated $51.5K increase.
  • Stralem & Co's biggest Q1 2018 reduction was Lowe's Companies, cutting an estimated $4.26M.
  • Stralem & Co fully exited Kraft Heinz in Q1 2018, selling an estimated $17.5M.
  • Stralem & Co's ten largest holdings make up 35% of its $503M portfolio in Q1 2018.
  • Stralem & Co opened 4 new positions and closed 3 in Q1 2018.
  • Stralem & Co's portfolio value fell 14% quarter-over-quarter to $503M.

Based on Stralem & Co's 13F filing for Q1 2018, filed 19 Apr 2018.